Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 89ZR-BEVACIZUMAB | 2件: Bevacizumab Bevacizumab (Bevacizumab),Bevacizumab zirconium Zr-89 (89ZR-BEVACIZUMAB) | 1件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr) 💬 1件:
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 1. 89ZR-BEVACIZUMAB
| 1件: VEGFA VEGFA 💬1. 89ZR-BEVACIZUMAB
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 1件: 34 34 💬1. 89ZR-BEVACIZUMAB
| |||||||||||||||||||||||||||||
| 2 | Bevacizumab | 1件: Bevacizumab Bevacizumab (Bevacizumab) | 1件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr) 💬 1件:
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 2. Bevacizumab
| 1件: VEGFA VEGFA 💬2. Bevacizumab
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 6件: 13 13, 34, 85, 87, 227, 280 💬2. Bevacizumab
| |||||||||||||||||||||||||||||
| 3 | Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) | 2件: Bevacizumab Bevacizumab (Bevacizumab),Imatinib | 2件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr),Imatinib 💬 2件: Bevacizumab (Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 3. Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
| 4件: ABL1 ABL1,KIT, PDGFRA, VEGFA 💬 | 45件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway, Viral myocarditis 💬 45件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bl ... | 1件: 87 87 💬3. Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
| |||||||||||||||||||||||||||||
| 4 | Bevacizumab (Genitical Recombination) | 1件: Bevacizumab Bevacizumab (Bevacizumab) | 1件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr) 💬 1件:
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 4. Bevacizumab (Genitical Recombination)
| 1件: VEGFA VEGFA 💬4. Bevacizumab (Genitical Recombination)
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 1件: 34 34 💬4. Bevacizumab (Genitical Recombination)
| |||||||||||||||||||||||||||||
| 5 | BEVACIZUMAB ZIRCONIUM ZR-89 | 2件: Bevacizumab Bevacizumab (Bevacizumab),Bevacizumab zirconium Zr-89 (89ZR-BEVACIZUMAB) | 1件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr) 💬 1件:
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 5. BEVACIZUMAB ZIRCONIUM ZR-89
| 1件: VEGFA VEGFA 💬5. BEVACIZUMAB ZIRCONIUM ZR-89
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 1件: 34 34 💬5. BEVACIZUMAB ZIRCONIUM ZR-89
| |||||||||||||||||||||||||||||
| 6 | Submucosal Bevacizumab | 1件: Bevacizumab Bevacizumab (Bevacizumab) | 1件: Bevacizumab
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr) 💬 1件:
Bevacizumab
(Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Be ... 6. Submucosal Bevacizumab
| 1件: VEGFA VEGFA 💬6. Submucosal Bevacizumab
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 1件: 227 227 💬6. Submucosal Bevacizumab
|